Raphael Pharmaceutical Inc. (RAPH): 8-K filed Sep 1, 2026

Form type

8-K

Filing date

Sep 1, 2026

Accession number

0001213900-26-096113

Filer

Raphael Pharmaceutical Inc. (CIK 1415397)